Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001300719 | SCV001489868 | likely benign | Alstrom syndrome | 2024-03-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002451668 | SCV002739956 | likely benign | Cardiovascular phenotype | 2019-11-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001300719 | SCV002078996 | uncertain significance | Alstrom syndrome | 2021-09-15 | no assertion criteria provided | clinical testing |